Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Lewis Acid Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102993253B reveals a reusable polymer-supported catalyst method for synthesizing capecitabine intermediates, offering significant supply chain stability and cost reduction in pharmaceutical manufacturing.
Novel HF/BF3 catalyzed formylation process offers high regioselectivity and yield for perfume intermediates, ensuring supply chain stability.
Patent CN102558127B details a green microwave-assisted route for high-purity polyhydroxy flavones, offering significant cost reduction and scalability for pharmaceutical manufacturers.
Patent CN107501156B details a one-pot synthesis for 2-cyano-3-arylpyrroles. This method offers significant cost reduction in API manufacturing and high-purity intermediates.
Novel metal-free synthesis of naphthofurans offers significant cost reduction and enhanced supply reliability for pharmaceutical intermediate manufacturing partners seeking high purity materials globally.
Patent CN108503573B details a high-purity Brivaracetam route eliminating chiral separation. This report analyzes cost reduction in API manufacturing and supply chain reliability for pharmaceutical intermediates.
Patent CN100564362C reveals a streamlined Lewis acid catalyzed route for Azoxystrobin, offering significant cost reduction and supply chain reliability for global agrochemical manufacturers.
Patent CN113831340B reveals a novel Lewis acid-catalyzed route for calix[n]dihydroacridine macrocycles, offering high yields and simplified purification for electronic chemical manufacturing.
Patent CN112979602B reveals a safer, scalable route for Baloxavir Marboxil intermediates, eliminating toxic selenium and cryogenic conditions for reliable supply.
Patent CN111116552B details a novel one-step synthesis of quinazolinones using vinyl heterocycles, offering high purity and scalable routes for pharmaceutical intermediate suppliers.
Novel one-step catalytic method for pyrido-pyrimidinones. Reduces synthetic steps, improves yield, and ensures supply chain stability for high-purity pharmaceutical intermediates.
Novel AlCl3 catalyzed route for IPTG ensures safe scalable cost-effective pharmaceutical intermediate manufacturing for global supply chains and research development needs
Patent CN103275146B reveals a scalable Gastrodin synthesis route. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN111943980B reveals a green B(C6F5)3-catalyzed synthesis of allyl phosphorus compounds, offering cost reduction and high purity for pharmaceutical manufacturing.
Patent CN111943980B reveals a green synthesis route for allyl phosphorus compounds using tris(pentafluorophenyl)borane, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN111943980B details a green B(C6F5)3 catalyzed synthesis of allyl phosphorus compounds, offering cost reduction in pharmaceutical intermediates manufacturing.
Patent CN103275146A details a novel Lewis acid-catalyzed route for gastrodin, offering significant cost reduction in API manufacturing and enhanced supply chain reliability through stable intermediates.
Patent CN101481381B introduces a green aqueous method for Ciprofloxacin production using Lewis acid catalysts, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN117964512B reveals a low-toxicity synthesis route for N,N-dimethyl-3-methoxypropionamide using Lewis acid catalysts, offering significant supply chain and cost advantages for industrial buyers.
Novel patent CN103145574B details efficient diclofenac sodium production. Enhances supply chain reliability and reduces manufacturing costs for global pharmaceutical intermediates.